• Bandeau Investisseurs

Key half-yearly figures from 2012 to 2020

In accordance with the evolution of IFRS without retroactive application

Balance sheet assets...

In EUR millions June 2020 June 2019 June 2018 June 2017 June 2016 June 2015 June 2014 June 2013 June 2012
Goodwill 24.15 24.15 24.53 21.67 21.67 21.79 21.79 21.79 22.29
Non-current assets 192.95 193.49 144.26 112.29 106.99 100.99 93.17 90.47 84.37
Current assets 346.51 364.97 311.69 267.07 259.44 232.58 194.45 179.51 170.73
Inventory 164.80 148.79 122.90 99.66 94.96 89.99 81.35 75.20 73.70
Receivables 116.23 154.96 135.60 119.30 123.04 111.26 89.89 81.11 74.84
Other receivables and cash 65.48 61.22 53.18 48.11 41.44 31.33 23.21 23.20 22.18

 Balance sheet liabilities...

In EUR millions June 2020 June 2019 June 2018 June 2017 June 2016 June 2015 June 2014 June 2013 June 2012
Shareholders' equity 119.76 136.45 126.77 122.94 116.70 99.36 84.63 74.71 68.81
Financial liabilities 252.30 237.58 170.39 125.16 118.57 110.06 93.57 97.36 95.72
Total liabilities and shareolders' equity 539.46 558.46 455.95 379.37 366.43 333.57 287.62 269.97 255.10

 Income statement...

In EUR millions June 2020 June 2019 June 2018 June 2017 June 2016 June 2015 June 2014 June 2013 June 2012
Turnover 201.99 264.18 226.56 218.17 221.77 183.04 163.82 145.66 145.74
Payroll charges 60.75 63.03 54.66 55.65 53.35 49.33 46.15 43.84 42.18
Operating profit -14.33 8.50 0.96 6.31 13.27 7.52 8.01 5.69 3.36
Net income -16.28 5.76 2.05 2.41 10.90 4.68 5.78 3.79 0.25

 Other indicators...

In EUR millions June 2020 June 2019 June 2018 June 2017 June 2016 June 2015 June 2014 June 2013 June 2012
Staff 3 810 3 809 3 516 3 315 3 141 2 921 2 763 2 673 2 773
Research & Development 38.47 41.79 39.44 31.66 29.78 25.12 22.47 21.53 22.91
EBITDA 0.21 21.61 15.25 11.07 21.03 12.92 14.44 11.43 6.95

 Ratios...

Percentage June 2020 June 2019 June 2018 June 2017 June 2016 June 2015 June 2014 June 2013 June 2012
Payroll charges / sales 30% 24% 24% 26% 24% 27% 28% 30% 29%
Net income / sales -8% 2% 1% 1% 5% 3% 4% 3% 0%
Net income / shareholders' equity -14% 4% 2% 2% 9% 5% 7% 5% 0%
Research & Development / sales 19% 16% 17% 15% 13% 14% 14% 15% 16%
Bookmark and Share